Demand Media, Inc. DMD 深 滬
等待開盤 08-11 09:30:00 美东时间
6.35
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 6.35
- 總市值 0
- 52周最高 6.35
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 4.41
- 委 比 0.00%
- 總股本 --
- 歷史最高 12.50
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.62
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多市值58亿美元，诺华拟收购Avidity Biosciences
（来源：CHC医疗传媒） 8月6日，据英国《金融时报》援引知情人士的话说，诺华最近几周表示对生物技术公司Avidity Biosciences感兴趣。《金融时报...
08-08 15:00
Edgewise Therapeutics GAAP EPS of -$0.34
Edgewise Therapeutics press release (NASDAQ:EWTX): Q2 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities were approximately $594.0 million as of June 30, 2025. More on Edgewise The...
08-07 21:17
Quince Therapeutics Enters Strategic Relationship With Option Care Health To Support The Commercial Development And Efficient Launch Of Quince's Lead Asset, Encapsulated Dexamethasone Sodium Phosphate In The U.S
Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that it has formed a strategic
08-07 20:09
Precision BioSciences GAAP EPS of -$2.13 misses by $0.56
Precision BioSciences press release (NASDAQ:DTIL): Q2 GAAP EPS of -$2.13 misses by $0.56. Extended expected cash runway to the second half of 2027 providing more than two years of operating cash More ...
08-07 19:56
一夜颠覆Sora神话，H200单卡5秒出片，全华人团队开源AI引爆视频圈
AI视频生成进入了秒生极速时代！UCSD等机构发布的FastWan系模型，在一张H200上，实现了5秒即生视频。稀疏蒸馏，让去噪时间大减，刷新SOTA。
08-07 15:27
Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date
NASHVILLE, Tenn., Aug. 5, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved ...
08-06 04:05
全栈贯通！知鱼智联斩获智慧园区全链路信创适配认证
近日，知鱼智联核心自研产品——ShareLink数智园区综合管理平台V3.11.0，一举斩获海光CPU生态兼容认证、麒麟操作系统、东方通中间件以及达...
08-05 18:52
Dyne gets FDA breakthrough therapy status for DMD therapy
Dyne Therapeutics (NASDAQ:DYN) said that it has received FDA's breakthrough therapy status for its experimental drug DYNE-251, aimed at treating patients with Duchenne muscular dystrophy. The FDA's de...
08-04 20:54
AAV基因治疗行业发展前景分析
（来源：老司机驾新车） 1、AV基础背景与特性 ·AV的定义与结构：AV是常用病毒载体，可将健康基因拷贝传递至患者细胞，已通过大量实验验证和临床研究。其为26纳...
08-03 17:46
Sarepta, Replimmune, Capricor rise as FDA’s biologics head departs
Sarepta Therapeutics (NASDAQ:SRPT), Replimune (NASDAQ:REPL), and Capricor Therapeutics (NASDAQ:CAPR), which faced regulatory setbacks from the FDA’s biologics division, recently witnessed sharp increa...
07-30 22:27
